Can Hormonal Therapy Improve the Outcomes of mTESE in Patients With Non‐Obstructive Azoospermia?
Mattia Anfosso, Maria Schubert, Jann‐Frederik Cremers, Sabine Kliesch, Michael Zitzmann, Simone Bier · 2026
Read Can Hormonal Therapy Improve the Outcomes of mTESE in Patients With Non‐Obstructive Azoospermia? by Mattia Anfosso, Maria Schubert, Jann‐Frederik Cremers, Sabine Kliesch, Michael Zitzmann, Simone Bier (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13432568.txt.
Description
Mattia Anfosso and co-authors looked back in 2026 at whether hormone care before a fine surgical sperm hunt lifts find rates in men whose testes make no sperm in the seed. The fault is the gravest form of male infertility, and low male hormone is common in this group. Records at one large center covered more than twelve hundred picked men from 2010 to 2024.
Half the men ran low on the hormone, most of them men with an extra sex chromosome. Hormone care raised blood levels in both gene groups by clear steps. Find rates still tied across cared and uncared men, at near a third overall. Younger age stood alone as the trait that forecast finds in the extra-chromosome group. The authors back hormone care for symptoms, not as a fertility booster before surgery.
Catalog record
| CREATOR | Mattia Anfosso, Maria Schubert, Jann‐Frederik Cremers, Sabine Kliesch, Michael Zitzmann, Simone Bier |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 54326 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |